A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to users administering products of uncertain source.
Several experts stated the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Content Elimination
Based on the social media company, the platform has taken down violative content and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also discovered communities with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at residence.
After minutes of joining one group, a vendor shared contact information, where most purchases take place. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these communities, posts show dark colored packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.
